Disease Overview：Small Intestinal Bacterial Overgrowth（SIBO）
Small Intestinal Bacterial Overgrowth (SIBO) is a gastrointestinal disorder characterized by excessive colonization of bacteria—typically commensal or colonic species—in the proximal small intestine. Unlike the large intestine, the small bowel normally maintains low bacterial counts (<10³ CFU/mL), but in SIBO, concentrations exceed 10⁵ CFU/mL, often leading to malabsorption, nutrient deficiencies (e.g., vitamin B12, fat-soluble vitamins), bloating, diarrhea or constipation, and systemic symptoms such as fatigue and brain fog. Diagnosis relies on clinical evaluation combined with hydrogen/methane breath testing after glucose or lactulose ingestion; jejunal aspirate culture remains the gold standard but is rarely performed due to invasiveness. Management involves targeted antimicrobial therapy (e.g., rifaximin ± neomycin), dietary modulation (low-FODMAP or elemental diets), prokinetic agents for motility disorders, and identification/treatment of underlying drivers—including pancreatic insufficiency, scleroderma, or prior gastric surgery.
China offers distinct advantages for SIBO management: leading digestive disease centers—such as Beijing Friendship Hospital and Shanghai Renji Hospital—employ multidisciplinary teams with deep expertise in functional and motility disorders, supported by advanced breath-testing platforms, high-resolution manometry, and comprehensive microbiome profiling. Success rates for symptom resolution and recurrence prevention align with international benchmarks, with published cohort studies reporting sustained improvement in >75% of patients after protocol-driven retreatment. Costs remain significantly lower than in the US or Western Europe—antibiotic regimens, diagnostic testing, and specialist consultations typically cost 40–60% less, without compromising quality or regulatory oversight. As your dedicated medical tourism agency, we facilitate seamless access to these accredited hospitals: arranging physician consultations, coordinating diagnostic workflows, providing transparent, all-inclusive pricing, and delivering end-to-end support—from visa assistance and accommodation to post-treatment follow-up coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Small Intestinal Bacterial Overgrowth (SIBO)
Non-Surgical / Conservative / Medication Options
*Target Criteria:* Confirmed via glucose/lactulose breath test (≥20 ppm H₂ rise within 90 min) or jejunal aspirate culture (>10⁵ CFU/mL); no structural obstruction or motility disorder requiring surgery.
- •First-Line Antibiotics (14-day course)
- *Neomycin 500 mg BID + Rifaximin*: ¥620–¥890 ($87–$125)
- •Diagnostic & Monitoring Fees
- Lactulose breath test: ¥360 ($50) - Serum vitamin B₁₂, folate, ferritin, CRP: ¥280 ($39) - Stool calprotectin & comprehensive microbiome PCR panel: ¥580 ($81)
- •Dietary & Adjunctive Therapy
- Prokinetic (prucalopride 1 mg OD, 3-month supply): ¥420 ($59)
Surgical / Procedural / Interventional Options
*Eligibility Criteria:* Documented anatomical cause (e.g., strictures, diverticula, fistulas) unresponsive to ≥2 antibiotic courses; confirmed via CT enterography or wireless motility capsule.
- •Preoperative Workup
- Wireless motility capsule study: ¥3,800 ($532) - Pre-anesthesia assessment (ECG, PFTs, labs): ¥650 ($91)
- •Procedures
- Resection + primary anastomosis (segmental ileal resection): ¥35,000–¥51,000 ($4,900–$7,140) - Endoscopic balloon dilation (for short-segment stricture): ¥12,500–¥18,000 ($1,750–$2,520)
Special / Complex Condition Options
- •Refractory SIBO (≥3 recurrences/year)
- Fecal Microbiota Transplant (colonoscopic delivery): ¥18,000–¥24,000–$3,360)
- •SIBO with Severe Malnutrition (BMI <16.5) nutritional rehabilitation (7 days, including IV amino acids, MCT oil, micronutrient repletion): ¥11,990)
Quick Selection Guide
- •Young adult (<45), mild-moderate, budget-conscious: Start with rifaximin monotherapy + breath test + dietitian consult (Total: ~$240)
- •Elderly (>70), comorbid diabetes/gastroparesis: Prucalopride + rifaximin-neomycin + prokinetic optimization (0)
- •Structural cause confirmed (e.g., Crohn’s stricture): Proceed directly to CT enterography →uroplasty (Total pre-op workup: $760; procedure: $4,9000)
- •Refractory, recurrent, immunocompetent: FMT after failed cyclical antibiotics (Total: $2,520–$3,360)
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Small Intestinal Bacterial Overgrowth Medical Vacation Packages
Curated transparent all-inclusive packages combining Small Intestinal Bacterial Overgrowth treatment with China top medical destinations:
